Full history for every metric is available with a Kvantra account
Erika B-Cure Laser Ltd (BCUR.TA)
Key financial summary
Financials in ILS| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | ILS m | 51 | 86 | 97 | 50 | 30 | 38 | -19 |
| Operating profit | ILS m | -10 | - | |||||
| Net profit | ILS m | 2 | 12 | -22 | -33 | -19 | -9 | - |
| EPS reported | ILS | -0.09 | - | |||||
| Operating cashflow per share | ILS | -0.04 | -0.04 | |||||
| Capex per share | ILS | 0.00 | 0.00 | |||||
| FCF per share | ILS | -0.04 | -0.04 | |||||
| Free cash flow | ILS m | -4 | 2 | |||||
| Net debt | ILS m | -4 | -5 | |||||
| Book value equity | ILS m | 15 | 13 | |||||
| Book value per share | ILS | 0.14 | 0.13 | |||||
| Number of shares | m | 104.17 | 105 | |||||
| DPS (TTM paid) | ILS | 0.00 | 0.00 |
Financial summary
Financials in ILS| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.61 | 1.31 | |||||
| P/S LTM | x | 0.64 | -0.95 | |||||
| P/FCF LTM | x | -5.62 | 11.00 | |||||
| EV/EBITDA LTM | x | -3.08 | -9.19 | |||||
| EV/Sales LTM | x | 0.67 | -0.67 | |||||
| Earnings Yield LTM | % | -39.02% | -54.11% | |||||
| FCF Yield | % | -17.80% | 9.09% | |||||
| Quality | ||||||||
| ROE | % | -62.98% | -48.86% | |||||
| ROIC | % | -46.49% | -46.49% | |||||
| Operating margin | % | -26.15% | -26.15% | |||||
| Gross margin | % | 68.62% | 68.62% | |||||
| FCF/Sales | % | -11.38% | -11.38% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +27.03% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.40 | 0.64 | |||||
| Net Debt/EBITDA | x | -0.16 | -0.16 | |||||
| EBIT/Net interest | x | -10.92 | -10.92 | |||||
| Net debt/market cap | % | -16.53% | -28.87% | |||||
| Net debt/Equity | x | -0.27 | -0.38 | |||||
| Gross debt/equity | x | 0.21 | 0.18 | |||||
Company overview
Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Erika B-Cure Laser Ltd (BCUR.TA)
Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free